Cancer Advisor

Evidence review updated: September 2026 Bottom line: EnteroMix is a genuine experimental Russian cancer immunotherapy, but it is not an approved cancer cure and it is not the same thing as Russia's personalized mRNA cancer-vaccine programme. EnteroMix is an oncolytic virotherapy based on four enteroviruses . As of 2026, the publicly registered human evidence remains an early Phase I study focused primarily on safety, tolerability, pharmacokinetics and dose selection. Claims of "100% efficacy," dramatic tumour regression, or a proven cancer cure go substantially beyond the publicly verifiable clinical evidence. Important: EnteroMix should not be confused with Russia's separate personalized mRNA cancer-vaccine programme. The two technologies have different mechanisms, development programmes and evidentiary status. Contents 1. What is EnteroMix? 2. The critical correction: EnteroMix is not the mRNA vaccine 3. How EnteroMix is intended to work ...

Colorectal cancer (CRC) remains one of the most formidable health challenges globally. While traditional treatments like surgery, chemotherapy, and targeted radiation have saved countless lives, advanced or metastatic cases can be incredibly stubborn to treat. This is particularly true for the over 80% of patients whose tumors are classified as "microsatellite stable" (MSS)—meaning they are "immune-cold" and practically invisible to modern breakthrough immunotherapies. Quick Summary: What is Oncolytic Virotherapy? Oncolytic Virotherapy (OV) is a cutting-edge cancer treatment that uses naturally occurring or genetically modified "good viruses" to selectively target, infect, and burst open cancer cells while leaving healthy cells untouched. This process exposes hidden tumor markers, effectively turning "immune-cold" tumors "hot" and training the body’s own immune system to hunt down and destroy colorectal cancer. The Big ...